Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2016

01-04-2016 | Progress in Hematology

Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?

Author: Atsushi Manabe

Published in: International Journal of Hematology | Issue 4/2016

Login to get access

Excerpt

Apart from acute lymphoblastic leukemia, pediatric diseases may not be well recognized by general hematologists focused on adults. However, several important diseases are manifested from infancy in the earliest stages of the human lifespan. Particular attention should be paid to inherited bone marrow failure syndromes (IBMFs) and myelodysplasia in children, as such diseases often remain latent until adulthood. …
Metadata
Title
Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
Author
Atsushi Manabe
Publication date
01-04-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-1966-6

Other articles of this Issue 4/2016

International Journal of Hematology 4/2016 Go to the issue

Original Article

Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy

Original Article

Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation

Case Report

Cytokine and viral load kinetics in human herpesvirus 8-associated multicentric Castleman’s disease complicated by hemophagocytic lymphohistiocytosis

Progress in Hematology

The current perspective of low-grade myelodysplastic syndrome in children

Original Article

Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors

Images in Hematology

Leukemic mastopathy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits